DiaMedica Therapeutics vs Supernus Pharmaceuticals
DiaMedica Therapeutics vs Supernus Pharmaceuticals, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: DiaMedica Therapeutics is on 35/100 and Supernus Pharmaceuticals on 60/100.
Where each one leads
DiaMedica Therapeutics
- agent readiness: 47/100 against 41/100
- funding raised: $30.1M against $17.5M
Supernus Pharmaceuticals
- our overall score: 60/100 against 35/100
- domain rating: 66/100 against 34/100
At a glance
| Measure | DiaMedica Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases. | Biopharmaceutical company developing and commercializing CNS disease treatments. |
| Category | Biotechnology, Healthcare, Pharmaceuticals | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Services |
| Founded | 2000 | 2005 |
| Headquarters | Minneapolis, United States | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | DiaMedica Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| Employees | Not published | 809 |
| Total funding | $30.1M | $17.5M |
| Latest round | Private Placement | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | DiaMedica Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 60/100 |
| Traction | 37/100 | 56/100 |
| Team | Not published | 30/100 |
| Search visibility | 11/100 | 15/100 |
| Quality | 45/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 66/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | DiaMedica Therapeutics | Supernus Pharmaceuticals |
|---|---|---|
| Hosting | AWS | AWS |
| Frameworks | Bootstrap | Tailwind CSS, Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
DiaMedica Therapeutics vs Supernus Pharmaceuticals: common questions
Which is better, DiaMedica Therapeutics or Supernus Pharmaceuticals?
On our 0-100 score Supernus Pharmaceuticals rates higher (60/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do DiaMedica Therapeutics and Supernus Pharmaceuticals compare on the numbers?
DiaMedica Therapeutics leads on agent readiness (47/100 against 41/100), funding raised ($30.1M against $17.5M). Supernus Pharmaceuticals leads on our overall score (60/100 against 35/100), domain rating (66/100 against 34/100).
Read the full DiaMedica Therapeutics review and pricing or the Supernus Pharmaceuticals review and pricing. You can also browse other DiaMedica Therapeutics alternatives we track.